BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32618436)

  • 21. Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children's Oncology Group, multicentre, phase 3 trial.
    Katzenstein HM; Langham MR; Malogolowkin MH; Krailo MD; Towbin AJ; McCarville MB; Finegold MJ; Ranganathan S; Dunn S; McGahren ED; Tiao GM; O'Neill AF; Qayed M; Furman WL; Xia C; Rodriguez-Galindo C; Meyers RL
    Lancet Oncol; 2019 May; 20(5):719-727. PubMed ID: 30975630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved survival outcome for hepatoblastoma based on an optimal chemotherapeutic regimen--a report from the study group for pediatric solid malignant tumors in the Kyushu area.
    Suita S; Tajiri T; Takamatsu H; Mizote H; Nagasaki A; Inomata Y; Hara T; Okamura J; Miyazaki S; Kawakami K; Eguchi H; Tsuneyoshi M;
    J Pediatr Surg; 2004 Feb; 39(2):195-8; discussion 195-8. PubMed ID: 14966739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration.
    Meyers RL; Maibach R; Hiyama E; Häberle B; Krailo M; Rangaswami A; Aronson DC; Malogolowkin MH; Perilongo G; von Schweinitz D; Ansari M; Lopez-Terrada D; Tanaka Y; Alaggio R; Leuschner I; Hishiki T; Schmid I; Watanabe K; Yoshimura K; Feng Y; Rinaldi E; Saraceno D; Derosa M; Czauderna P
    Lancet Oncol; 2017 Jan; 18(1):122-131. PubMed ID: 27884679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma.
    Malogolowkin MH; Katzenstein H; Krailo MD; Chen Z; Bowman L; Reynolds M; Finegold M; Greffe B; Rowland J; Newman K; Womer RB; London WB; Castleberry RP
    J Clin Oncol; 2006 Jun; 24(18):2879-84. PubMed ID: 16782927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children's Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children's Oncology Group.
    O'Neill AF; Towbin AJ; Krailo MD; Xia C; Gao Y; McCarville MB; Meyers RL; McGahren ED; Tiao GM; Dunn SP; Langham MR; Weldon CB; Finegold MJ; Ranganathan S; Furman WL; Malogolowkin M; Rodriguez-Galindo C; Katzenstein HM
    J Clin Oncol; 2017 Oct; 35(30):3465-3473. PubMed ID: 28892430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cisplatin and carboplatin pharmacokinetics in a pediatric patient with hepatoblastoma receiving peritoneal dialysis.
    Nijstad AL; van Eijkelenburg NKA; Kraal KCJM; Meijs MJM; de Kanter CTMM; Lilien MR; Huitema ADR
    Cancer Chemother Pharmacol; 2020 Sep; 86(3):445-449. PubMed ID: 32816154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach--results of the first prospective study of the International Society of Pediatric Oncology.
    Pritchard J; Brown J; Shafford E; Perilongo G; Brock P; Dicks-Mireaux C; Keeling J; Phillips A; Vos A; Plaschkes J
    J Clin Oncol; 2000 Nov; 18(22):3819-28. PubMed ID: 11078495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Outcome of hepatoblastoma: experience with 63 patients received chemotherapy with the regimen C5V].
    Liu G; Liu B; Li K; Dong K; Xiao X
    Zhonghua Er Ke Za Zhi; 2015 Feb; 53(2):119-23. PubMed ID: 25876687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of children with hepatoblastoma who underwent liver resection at a tertiary hospital in China: a retrospective analysis.
    Li J; Li H; Wu H; Niu H; Li H; Pan J; Yang J; Tan T; Hu C; Xu T; Zhang X; Zheng M; Li K; Zou Y; Yang T
    BMC Pediatr; 2020 May; 20(1):200. PubMed ID: 32386507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved long-term survival with preoperative chemotherapy for hepatoblastoma.
    Ehrlich PF; Greenberg ML; Filler RM
    J Pediatr Surg; 1997 Jul; 32(7):999-1002; discussion 1002-3. PubMed ID: 9247221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changing treatment and outcome of children with hepatoblastoma: analysis of a single center experience over the last 20 years.
    Ismail H; Broniszczak D; Kaliciński P; Dembowska-Bagińska B; Perek D; Teisseyre J; Kluge P; Kościesza A; Lembas A; Markiewicz M
    J Pediatr Surg; 2012 Jul; 47(7):1331-9. PubMed ID: 22813792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A trend of improved survival of childhood hepatoblastoma treated with cisplatin and doxorubicin in Taiwanese children.
    Chiu SN; Ni YH; Lu MY; Lin DT; Lin KH; Lai HS; Chang MH
    Pediatr Surg Int; 2003 Oct; 19(8):593-7. PubMed ID: 14556026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma.
    Perilongo G; Maibach R; Shafford E; Brugieres L; Brock P; Morland B; de Camargo B; Zsiros J; Roebuck D; Zimmermann A; Aronson D; Childs M; Widing E; Laithier V; Plaschkes J; Pritchard J; Scopinaro M; MacKinlay G; Czauderna P
    N Engl J Med; 2009 Oct; 361(17):1662-70. PubMed ID: 19846851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility of dose-dense cisplatin-based chemotherapy in Japanese children with high-risk hepatoblastoma: Analysis of the JPLT3-H pilot study.
    Watanabe K; Mori M; Hishiki T; Yokoi A; Ida K; Yano M; Fujimura J; Nogami Y; Iehara T; Hoshino K; Inoue T; Tanaka Y; Miyazaki O; Takimoto T; Yoshimura K; Hiyama E
    Pediatr Blood Cancer; 2022 Feb; 69(2):e29389. PubMed ID: 34606680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome and Late Complications of Hepatoblastomas Treated Using the Japanese Study Group for Pediatric Liver Tumor 2 Protocol.
    Hiyama E; Hishiki T; Watanabe K; Ida K; Ueda Y; Kurihara S; Yano M; Hoshino K; Yokoi A; Takama Y; Nogami Y; Taguchi T; Mori M; Kihira K; Miyazaki O; Fuji H; Honda S; Iehara T; Kazama T; Fujimura J; Tanaka Y; Inoue T; Tajiri T; Kondo S; Oue T; Yoshimura K
    J Clin Oncol; 2020 Aug; 38(22):2488-2498. PubMed ID: 32421442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome and complications after resection of hepatoblastoma.
    Towu E; Kiely E; Pierro A; Spitz L
    J Pediatr Surg; 2004 Feb; 39(2):199-202; discussion 199-202. PubMed ID: 14966740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical characteristics and risk factors of 47 cases with ruptured neuroblastoma in children.
    Qin H; Yang S; Cai S; Ren Q; Han W; Yang W; Cheng H; Ma X; Wang H
    BMC Cancer; 2020 Mar; 20(1):243. PubMed ID: 32293329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment-related acute myelomonocytic leukemia with t(11;19) in a child following chemotherapy for hepatoblastoma.
    Koga Y; Matsuzaki A; Suminoe A; Washitoh N; Hara T; Hara T; Tajiri T; Taguchi T
    Pediatr Blood Cancer; 2008 Apr; 50(4):943-4. PubMed ID: 17973320
    [No Abstract]   [Full Text] [Related]  

  • 39. Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94.
    Fuchs J; Rydzynski J; Von Schweinitz D; Bode U; Hecker H; Weinel P; Bürger D; Harms D; Erttmann R; Oldhafer K; Mildenberger H;
    Cancer; 2002 Jul; 95(1):172-82. PubMed ID: 12115331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology.
    von Schweinitz D; Byrd DJ; Hecker H; Weinel P; Bode U; Bürger D; Erttmann R; Harms D; Mildenberger H
    Eur J Cancer; 1997 Jul; 33(8):1243-9. PubMed ID: 9301450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.